Upregulaton of ATAD2 in cancer tissues compared to paired normal tissues has been reported previously in multiple cancers, such as renal cell carcinoma 22, breast cancer 23 and prostate cancer 24. This evidence concerns the gene ATAD2 and breast cancer.